CW July 2006
Volume 15Issue Number 7 July 2006 ISSN 10593802 Zoledronic Acid Improves Survival in Lung Cancer and Multiple MyelomaA bisphosphonate used in osteoporosis appears to improve survival of lung cancer and multiple myeloma patients with high levels of bone metabolism, according to reports from the American Society of Clinical Oncology Annual Meeting.
Go to Previous Page Go to Next Page Source & Additional Reading American Society of Clinical Oncology Annual Meeting. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
